Gyala Therapeutics Unveils Promising CAR-T Therapy Targeting CD84
Gyala Therapeutics has announced preclinical results demonstrating the efficacy of its CAR-T therapy, GYA01, targeting the CD84 protein in leukemia.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Gyala Therapeutics has announced preclinical results demonstrating the efficacy of its CAR-T therapy, GYA01, targeting the CD84 protein in leukemia.
ARTHEx Biotech has successfully closed an upsized Series B financing round, raising $87 million to advance its lead program ATX-01 for Myotonic Dystrophy Type 1.
Senhwa Biosciences has announced a collaboration with Sanofi and Regeneron Pharmaceuticals to evaluate its drug Pidnarulex in combination with Cemiplimab for colorectal cancer treatment.
Mount Sinai Fuster Heart Hospital has launched the Samuel Fineman Cardiac Catheterization Artificial Intelligence Research Lab to enhance interventional cardiology through AI.
ProofPilot has acquired Lokavant to integrate predictive analytics into its clinical trial platform, enhancing trial execution and data insights.
University Lab Partners and BARDA have announced the ReadyDetect competition, offering $10 million to advance next-generation diagnostics for detecting key pathogens.
PhaseV will showcase its AI/ML advancements for clinical trials at upcoming biopharma events, highlighting their impact on trial efficiency and success.
p36 GmbH has introduced UDI Connect, a SaaS solution aimed at automating compliance processes for medical device companies, as announced in a press release.
BEVIMI, a new brain health and wellness company, was launched at the CG Well Summit, focusing on cognitive longevity through AI-driven solutions.
Armor Health has announced a partnership with Antidote-AI to integrate AI clinical tools into its Insights Analytics platform, enhancing healthcare in correctional facilities.
MGI Tech Co., Ltd. has launched the DNBSEQ-T7+, a high-throughput sequencer designed for large-scale genomic research, offering over 14 terabases of data per day.
Cardinality.ai has launched CardyCares, an AI-powered suite designed to modernize Medicaid Enterprise Systems, as announced in a press release. The suite aims to automate routine tasks and improve healthcare outcomes.
Imaging Endpoints has filed a provisional patent for its AI-powered Imaging Review Charter system, designed to enhance clinical trial imaging standards.
Homecare Homebase and Element5 have announced a strategic alliance to integrate AI into post-acute care, aiming to improve operational efficiency and patient care.
The University of Utah is collaborating with Hewlett Packard Enterprise and NVIDIA to enhance AI research capabilities, focusing on medical breakthroughs and mental health.
uLab Systems and Biolux Technology have announced a strategic partnership to bundle uSmile aligners with the OrthoPulse device, aiming to accelerate clear aligner treatment with light therapy.
Eko Health's AI-enabled stethoscopes significantly improve detection rates of heart conditions, as shown in the TRICORDER study conducted across NHS GP practices.
Naitive Technologies has received FDA 510(k) clearance for OsteoSight, an AI-driven tool for assessing bone mineral density using standard X-rays. This advancement aims to improve early diagnosis and intervention in osteoporosis management.
Goodpath has raised $18 million in Series A funding, led by MassMutual Ventures, to enhance its AI-driven care model for chronic conditions.
Penguin Ai has secured $29.7 million in venture funding, including a $25M Series A led by Greycroft, to enhance its AI platform for healthcare administration.